Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
about
Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicityRole of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determinationPenetration of moxifloxacin into bone evaluated by Monte Carlo simulation.Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.Penetration of vancomycin into mediastinal and cardiac tissues in humans.Levels of vancomycin in the cerebral interstitial fluid after severe head injury.Pharmacokinetics of Cefuroxime in Synovial Fluid.The In Vitro Susceptibility of Biofilm Forming Medical Device Related Pathogens to Conventional Antibiotics
P2860
Q28343011-D82D6720-87AA-4565-BE47-FC9FD3A4FCAAQ33750776-58E325E8-94ED-4A22-9BC5-F99471A2AD87Q33979524-4A7CF343-0245-4038-8559-B049FB18E8AAQ35285000-6CE7BF84-B9D7-4555-9B92-9753F3DD7764Q37190660-EEAD85FF-7017-46B2-9D3A-EC87CC1CE8A8Q39781743-FB42561C-6286-40FB-89C1-284673B336DBQ39815613-1E105748-ED17-4577-8170-19DEBFBC09A7Q40088863-634C6FEC-7859-4343-9D48-64A767CC0D6FQ40285124-FA556346-C710-41ED-A8C4-2E49BCE367B7Q46908278-D034AEAF-5E80-410B-9053-663DED2C52F5Q47265801-544AC18E-26D4-4927-8131-0490351E87D3Q59039985-23D87150-5DE9-44D6-9FA2-3E0146B01142
P2860
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
description
1987 nî lūn-bûn
@nan
1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Activity of LY146032 compared ...... mined by kill-kinetic studies.
@ast
Activity of LY146032 compared ...... mined by kill-kinetic studies.
@en
type
label
Activity of LY146032 compared ...... mined by kill-kinetic studies.
@ast
Activity of LY146032 compared ...... mined by kill-kinetic studies.
@en
prefLabel
Activity of LY146032 compared ...... mined by kill-kinetic studies.
@ast
Activity of LY146032 compared ...... mined by kill-kinetic studies.
@en
P2093
P2860
P356
P1476
Activity of LY146032 compared ...... mined by kill-kinetic studies.
@en
P2093
P2860
P304
P356
10.1128/AAC.31.8.1210
P407
P577
1987-08-01T00:00:00Z